Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-25T16:50:08.115Z Has data issue: false hasContentIssue false
  • English
  • Français

Total cost of surgical site infection in the two years following primary knee replacement surgery

Published online by Cambridge University Press:  28 May 2020

Lynn N. Lethbridge Open the ORCID record for Lynn N. Lethbridge [Opens in a new window] ,
C. Glen Richardson  and
Michael J. Dunbar
Lynn N. Lethbridge*
Affiliation:
Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada
C. Glen Richardson
Affiliation:
Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada
Michael J. Dunbar
Affiliation:
Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada
*
Author for correspondence: Lynn N. Lethbridge, E-mail: Lynn.Lethbridge@dal.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The disease burden of surgical site infection (SSI) following total knee (TKA) replacement is considerable and is expected to grow with increased demand for the procedure. Diagnosing and treating SSI utilizes both inpatient and outpatient services, and the timing of diagnosis can affect health service requirements. The purpose of this study was to estimate the health system costs of infection and to compare them across time-to-diagnosis categories.

Methods:

Administrative data from 2005–2016 were used to identify cases diagnosed with SSI up to 1 year following primary TKA. Uninfected controls were selected matched on age, sex and comorbidities. Costs and utilization were measured over the 2-year period following surgery using hospital and out-of-hospital data. Costs and utilization were compared for those diagnosed within 30, 90, 180, and 365 days. A subsample of cases and controls without comorbidities were also compared.

Results:

We identified 238 SSI cases over the study period. On average, SSI cases cost 8 times more than noninfected controls over the 2-year follow-up period (CaD$41,938 [US$29,965] vs CaD$5,158 [US$3,685]) for a net difference of CaD$36,780 (US$26,279). The case-to-control ratio for costs was lowest for those diagnosed within 30 days compared to those diagnosed later. When only patients without comorbidities were included, costs were >7 times higher.

Conclusion:

Our results suggest that considerable costs result from SSI following TKA and that those costs vary depending on the time of diagnosis. A 2-year follow-up period provided a more complete estimate of cost and utilization.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 41 , Issue 8 , August 2020 , pp. 938 - 942
Check for updates
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: A version of this work was accepted and presented at the 2018 International Population Data Linkage Conference, September 12–14, 2018, in Banff, Alberta, Canada.

References

Kurtz, SM, Lau, E, Schmier, J, Ong, KL, Zhao, K, Parvizi, J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008;23:984–991.CrossRefGoogle ScholarPubMed
Leaper, DJ, van Goor, H, Reilly, J, et al.Surgical site infection—a European perspective of incidence and economic burden. Int Wound J 2004;1:247–273.CrossRefGoogle ScholarPubMed
Segreti, J, Parvizi, J, Berbari, E, Ricks, P, Berríos-Torres, SI. Introduction to the Centers for Disease Control and Prevention and Healthcare Infection Control Practices Advisory Committee guideline for prevention of surgical site infection: prosthetic joint arthroplasty section. Surg Infect 2017;18:394–400.CrossRefGoogle ScholarPubMed
Zimmerli, W, Trampuz, A, Ochsner, PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645–1654.CrossRefGoogle ScholarPubMed
Berríos-Torres, SI, Umscheid, CA, Bratzler, DW, et al.Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 2017;152:784–791.Google Scholar
Wolford, HM, Hatfield, KM, Paul, P, Yi, SH, Slayton, RB. The projected burden of complex surgical site infections following hip and knee arthroplasties in adults in the United States, 2020 through 2030. Infect Control Hosp Epidemiol 2018;39:1189–1195.CrossRefGoogle ScholarPubMed
Davies, BM, Patel, HC. Letter to the editor: Is a reduced duration of post-discharge surgical site infection surveillance really in our best interests. Euro Surveill 2015;20(13):42.CrossRefGoogle ScholarPubMed
Yokoe, DS, Avery, TR, Platt, R, Huang, SS. Reporting surgical site infections following total hip and knee arthroplasty: impact of limiting surveillance to the operative hospital. Clin Infect Dis 2013;57:1282–1288.CrossRefGoogle ScholarPubMed
Jenks, PJ, Laurent, M, McQuarry, S, Watkins, R. Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. J Hosp Infect 2014;86:24–33.CrossRefGoogle ScholarPubMed
Graves, N, Weinhold, D, Tong, E, et al.Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol 2007;28:280–292.CrossRefGoogle ScholarPubMed
Peel, TN, Cheng, AC, Liew, D, et al.Direct hospital cost determinants following hip and knee arthroplasty. Arthritis Care Res 2015;67:782–790.CrossRefGoogle ScholarPubMed
Boltz, MM, Hollenbeak, CS, Julian, KG, Ortenzi, G, Dillon, PW. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery 2011;150:934–942.CrossRefGoogle ScholarPubMed
Gow, N, McGuinness, C, Morris, AJ, McLellan, A, Morris, JT, Roberts, SA. Excess cost associated with primary hip and knee joint arthroplasty surgical site infections: a driver to support investment in quality improvement strategies to reduce infection rates. N Z Med J 2016;129:51–58.Google ScholarPubMed
Kaye, KS, Marchaim, D, Chen, T-Y, et al.Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. J Am Geriatr Soc 2014;62:306–311.CrossRefGoogle ScholarPubMed
Whitehouse, JD, Friedman, ND, Kirkland, KB, Richardson, WJ, Sexton, DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23:183–189.CrossRefGoogle Scholar
Miletic, KG, Taylor, TN, Martin, ET, Vaidya, R, Kaye, KS. Readmissions after diagnosis of surgical site infection following knee and hip arthroplasty. Infect Control Hosp Epidemiol 2014;35:152–157.CrossRefGoogle ScholarPubMed
González-Vélez, AE, Romero-Martín, M, Villanueva-Orbaiz, R, Díaz-Agero-Pérez, C, Robustillo-Rodela, A, Monge-Jodra, V. The cost of infection in hip arthroplasty: a matched case-control study. Rev Espanola Cirugia Ortop Traumatol 2016;60:227–233.Google ScholarPubMed
Badia, JM, Casey, AL, Petrosillo, N, Hudson, PM, Mitchell, SA, Crosby, C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect 2017;96:1–15.CrossRefGoogle ScholarPubMed
Broex, ECJ, van Asselt, ADI, Bruggeman, CA, van Tiel, FH. Surgical site infections: how high are the costs? J Hosp Infect 2009;72:193–201.CrossRefGoogle ScholarPubMed
Kurtz, SM, Ong, KL, Schmier, J, et al.Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Jt Surg Am 2007;89 suppl 3:144–151.CrossRefGoogle Scholar
Lethbridge, LN, Richardson, CG, Dunbar, MJ. Measuring surgical site infection from linked administrative data following hip and knee replacement. J Arthroplasty 2020;35:528–533.CrossRefGoogle ScholarPubMed
Rennert-May, E, Manns, B, Smith, S, et al.Validity of administrative data in identifying complex surgical site infections from a population-based cohort after primary hip and knee arthroplasty in Alberta, Canada. Am J Infect Control 2018;46:1123–1126.CrossRefGoogle ScholarPubMed
Cost of a standard hospital stay. Canadian Institutes of Health Research website. https://yourhealthsystem.cihi.ca/hsp/inbrief?lang=en#!/indicators/015/cost-of-a-standard-hospital-stay/;mapC1;mapLevel2;overview;/. Accessed May 24, 2019.Google Scholar
Moura, J, Baylina, P, Moreira, P. Exploring the real costs of healthcare-associated infections: an international review. Int J Healthcare Manag 2018;11:333–340.CrossRefGoogle Scholar
Kapadia, BH, McElroy, MJ, Issa, K, Johnson, AJ, Bozic, KJ, Mont, MA. The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplasty 2014;29:929–932.CrossRefGoogle Scholar
Guirro, P, Hinarejos, P, Pelfort, X, Leal-Blanquet, J, Torres-Claramunt, R, Puig-Verdie, L. Long term follow-up of successfully treated superficial wound infections following TKA. J Arthroplasty 2015;30:101–103.CrossRefGoogle ScholarPubMed
Johnson, DP, Bannister, GC. The outcome of infected arthroplasty of the knee. J Bone Joint Surg Br 1986;68:289–291.CrossRefGoogle ScholarPubMed
Carroll, K, Dowsey, M, Choong, P, Peel, T. Risk factors for superficial wound complications in hip and knee arthroplasty. Clin Microbiol Infect 2014;20:130–135.CrossRefGoogle ScholarPubMed
Galat, DD, McGovern, SC, Larson, DR, Harrington, JR, Hanssen, AD, Clarke, HD. Surgical treatment of early wound complications following primary total knee arthroplasty. J Bone Joint Surg Am 2009;91:48–54.CrossRefGoogle ScholarPubMed
Ridgeway, S, Wilson, J, Charlet, A, Kafatos, G, Pearson, A, Coello, R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 2005;87:844–850.CrossRefGoogle ScholarPubMed
Kurtz, SM, Ong, KL, Schmier, J, et al.Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007;89 suppl 3:144–151.CrossRefGoogle Scholar
Cunningham, CT, Cai, P, Topps, D, Svenson, LW, Jetté, N, Quan, H. Mining rich health data from Canadian physician claims: features and face validity. BMC Res Notes 2014;7:682.CrossRefGoogle ScholarPubMed
Stevenson, KB, Khan, Y, Dickman, J, et al.Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care–associated infections. Am J Infect Control 2008;36:155–164.CrossRefGoogle ScholarPubMed
O’malley, KJ, Cook, KF, Price, MD, Wildes, KR, Hurdle, JF, Ashton, CM. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005;40:1620–1639.CrossRefGoogle ScholarPubMed
Drees, M, Gerber, JS, Morgan, DJ, Lee, GM. Research methods in healthcare epidemiology and antimicrobial stewardship: use of administrative and surveillance databases. Infect Control Hosp Epidemiol 2016;1–10.Google Scholar